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ABSTRACT 
 Background 
Diastolic dysfunction is increasingly recognized as a major contributor to cardiac morbidity and 
mortality in a background ischaemic heart disease. This study determined the effect of 
percutaneous coronary intervention (PCI) on diastolic dysfunction in patients with coronary 
artery disease. 
Methods 
Forty two patients with coronary artery disease who underwent PCI for ACS at HUSM 
from December 2013 to May 2014were enrolled in the study. All patients had PCI and 
underwent Doppler Echocardiographic examination within 48hours before PCI, 48 hours after 
PCI and at 3 months after PCI for evaluation of LV function. Mean differences in Echo was 
determined using Multifactorial repeated measure ANOVA.  
 
 
Results 
 The mean age of the study patients was 59.3 + 8.1 years. Thirty six patients were male 
with 6 female patients. Almost all patients (40 patients) had mild to moderate degree of left 
ventricular diastolic dysfunction before PCI. All the study patients had severe coronary artery 
disease with more than 70% occlusion of the involved coronary artery. The E/A ratio before PCI 
(0.99+0.43) compared with post PCI within 48 hours (1.12+0.46) showed significant 
improvement but no progressive improvement at three months of PCI (1.10+0.31). Isovolumic 
relaxation time (IVRT) of 106.8+24.5 before PCI versus 89.0+23.8 at 48 hours versus 89.9+19.5 
at 3 months after PCI also showed remarkable improvement. Improvement was also noted in 
deceleration time DT, 224.0+49.5 versus 211+45.6 versus 201+37.3. The E'/A' obtained from 
Tissue Doppler imaging also showed improvement noticeable within 48 hours  0.65+ 0.33 versus 
1.06+ 0.52 versus 1.05+0.35. It was statistically significant (P=0.006) that diastolic dysfunction 
improved within 48 hours of PCI. There was no significantsustained/progressive improvement 
after 48 hours of PCI to three months of PCI (P=0.965).. Left anterior descending artery (LAD) 
disease patients were found to have more heart failure as a complication following MI.A 
significant difference was found between pre-PCI and 48hours post-PCI (p=0.006) and between 
pre-PCI and 3 months post-PCI (0.001). No significant difference was found between 48 hours 
post-PCI and 3 months post-PCI.There was association found between the severity of LAD  
disease and severity of diastolic dysfunction.Also there was association between LAD disease 
and diastolic dysfunction. 
 
 
 
Conclusion 
 Improvement of diastolic dysfunction after PCI as demonstrated in this study showed 
that PCI is an effective mode of treatment for diastolic dysfunction in patients with significant 
coronary artery disease. This may significantly reduce morbidity and mortality in these patients. 
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KESAN INTERVENSI KORONARI PERKUTANEOUS (PCI) PADA 
DISFUNGSI DIASTOLIK DALAM PENYAKIT ARTERI KORONARI 
ABSTRAK 
Penyakit koronari arteri merupakan penyebab kardiovaskular yang penting dan utama yang 
menyebabkan kematian di seluruh dunia. Terdapat banyak kemajuan dalam pengurusan penyakit 
arteri koronari terutamanya dalam revaskularisasi saluran darah tersumbat. Fungsi diastolik tidak 
normal semakin diiktiraf sebagai penyumbang utama kepada morbiditi jantung dan kematian 
dalam kes penyakit jantung iskemia. Oleh kerana itu, peranan intervensi perkutaneus koronari 
(PCI) sebagai terapi untuk penyakit arteri koronari( CAD) perlu dinilai dalam meningkatkan 
disfungsi diastolik. Objektif kajian ini adalah untuk menilai kesan PCI pada disfungsi diastolik 
pada pesakit yang mempunyai penyakit arteri koronari melalui parameter Doppler 
Ekokardiografik. 
Kaedah: Empat puluh dua pesakit yang mempunyai penyakit arteri koronari yang memenuhi 
kriteria kemasukan telah mendaftar dalam kajian ini. Semua pesakit mempunyai  PCI dan semua 
pesakit telah menjalani pemeriksaan Doppler Ekokardiografik pada 3 bulan PCI, untuk penilaian 
fungsi LV. 
Hasil: Purata umur pesakit kajian adalah 59.3 + 8.1 tahun. 36 pesakit lelaki dengan 6 pesakit 
perempuan. Hampir semua pesakit (40 pesakit )mempunyai tahap disfungsi diastolik daripada 
lemah kepada sederhana sebelum PCI. Semua pesakit kajian mempunyai penyakit arteri koronari 
yang teruk dengan lebih daripada 70% arteri koronari yang terlibat . 
Nisbah EIA sebelum PCI (0.99 + 0.43 ) berbanding dengan kedudukan selepas PCI dalam masa 
48 jam ( 1.12 + 0.46 ) menunjukkan peningkatan yang ketara tetapi tiada peningkatan progresif 
pada 3 bulan daripada PCI (1.10 + 0.31 ). Masa rehat Isovolumic (IVRT) daripada 106.8 + 24.5 
sebelum PCI berbanding 89.0 + 23.8 pada 48 jam selepas PCI berbanding 89.9 + 19.5 pada 3 
bulan PCI juga menunjukkan peningkatan yang luar biasa . 
Peningkatan juga dicatatkan dalam masa Kelembapan (DT) 224.0 + 49.5 berbanding 211 + 45.6 
berbanding 201 + 37.3. E'/A' diperolehi daripada tisu pengimejan Doppler juga menunjukkan 
peningkatan yang ketara dalam tempoh 48 jam PCI  0.65 + 0.33 berbanding 1.06 + 0.52 
berbanding 1.05 + 0.35. 
Ia adalah statistik yang signifikan (P-0.006) bahawa disfungsi diastolik bertambahbaik dalam 
tempoh 48 jam PCI. Tiada perubahan yang berterusan atau progresif yang ketara selepas 48 jam 
PCI hingga 3 bulan selepas PCI (P-0.965). Tiada perkaitan di antara tahap keterukan penyakit 
arteri koronari dan tahap disfungsi diastolik. Pesakit yang menghidap penyakit arteri kiri 'anterior 
descending' (LAD) didapati mempunyai kegagalan jantung yang lebih teruk akibat komplikasi 
MI. 
Kesimpulan: Peningkatan disfungsi diastolik selepas PCI seperti yang ditunjukkan dalam kajian 
ini menunjukkan bahawa PCI ialah mod rawatan berkesan untuk disfungsi diastolik pada pesakit 
dengan significant penyakit arteri koronari. Ini boleh mengurangkan morbiditi dan kematian 
dalam kalangan pesakit-pesakit ini. 
 
 
 
 
 
 
ABSTRACT 
 Background 
    Coronary artery disease is an important and major cardiovascular cause of morbidity and 
mortality worldwide. There has been much progress made in the management of coronary 
disease especially in revascularisation of the occluded coronary blood vessel. Abnormal diastolic 
function is increasingly recognised as a significant contributor to cardiac morbidity and mortality 
in the setting of ischemic heart disease; because of this, the role of percutaneous coronary 
intervention (PCI) as a therapy for coronary artery disease (CAD) should be evaluated in 
improving diastolic dysfunction. The objective of this study is to evaluate the impact of PCI on 
diastolic dysfunction in CAD patients by Doppler Echocardiographic parameters. 
Methods 
 Forty two patients with coronary artery disease who fulfilled the inclusion criteria were 
enrolled in this study. All the patients had PCI and all patients underwent Doppler 
Echocardiographic examination within 48 hours before PCI, within 48 hours after PCI and at 
three months of PCI for evaluation LV function. 
Results 
 The mean age of the study patients was 59.3 + 8.1 years. Thirty six patients were male 
with 6 female patients. Almost all patients (40 patients) had mild to moderate degree of left 
ventricular diastolic dysfunction before PCI. All the study patients had severe coronary artery 
disease with more than 70% occlusion of the involved coronary artery. The E/A ratio before PCI 
(0.99+0.43) compared with post PCI within 48 hours (1.12+0.46) showed significant 
improvement but no progressive improvement at three months of PCI (1.10+0.31). Isovolumic 
relaxation time (IVRT) of 106.8+24.5 before PCI versus 89.0+23.8 at 48 hours versus 89.9+19.5 
at 3 months after PCI also showed remarkable improvement. Improvement was also noted in 
deceleration time DT, 224.0+49.5 versus 211+45.6 versus 201+37.3. The E'/A' obtained from 
Tissue Doppler imaging also showed improvement noticeable within 48 hours  0.65+ 0.33 versus 
1.06+ 0.52 versus 1.05+0.35. It was statistically significant (P=0.006) that diastolic dysfunction 
improved within 48 hours of PCI. There was no significantsustained/progressive improvement 
after 48 hours of PCI to three months of PCI (P=0.965). There was association found between 
the severity of coronary artery disease and severity of diastolic dysfunction. Left anterior 
descending artery (LAD) disease patients were found to have more heart failure as complication 
following MI. 
Conclusion 
 Improvement of diastolic dysfunction after PCI as demonstrated in this study showed 
that PCI is an effective mode of treatment for diastolic dysfunction in patients with significant 
coronary artery disease. This can significantly reduce morbidity and mortality in these patients. 
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CHAPTER ONE 
1.1 Introduction  
 Coronary artery disease (CAD) is a major cause of morbidity and mortality 
worldwide. It is characterized pathophysiologically by progressive occlusive atherosclerosis, 
acute plaque rupture and thrombosis (Owan et al., 2006). ACS encompasses a broad spectrum 
of clinical conditions from unstable angina (UA) to non-ST-segment elevation infarct 
(NSTEMI) with micro-necrosis and through to trans mural ST-elevation myocardial infarction 
(STEMI)  (Libby, 2001; Gaasch et al., 2009).  
 There has been much progress made in the management of coronary heart disease, 
especially in revascularisation of the occluded coronary blood vessels. Abnormal diastolic 
function is increasingly recognized as a major contributor to cardiac morbidity and mortality 
in the setting of ischaemic heart disease. Advances in echocardiographic assessment of left 
ventricular diastolic function can lead to replacement of invasive hemodynamic methods in 
vast majority of patients. 
 Diastolic dysfunction and coronary artery disease (CAD) are interrelated. The 
complications of CAD, myocardial ischemia or infarction, are major causes of diastolic 
dysfunction. Noninvasive measurement of diastolic dysfunction during stress testing can 
detect myocardial ischemia, and the presence of resting diastolic dysfunction identifies 
patients with poor prognosis. About half of heart failure patients, acute or chronic, have 
preserved ejection function, heart failure with preserved ejection fraction: HFpEF  
(Braunwald et al., 2002).The WHO estimated that CAD will be the single largest cause of the 
disease burden in many countries worldwide by the year 2020. In the USA, every year nearly 
1.2 million patients are hospitalized for ACS. 
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It is estimated that more than 16 million Americans have coronary artery disease (CAD) and 8 
million have had a myocardial infarction (MI). Based on data from the Framingham trial 
nearly 50% of males and 30% of females over the age of 40 years will develop coronary 
artery disease (Owan et al., 2006).  
 According to the epidemiological databases of cardiovascular disease in Malaysia, 
(Medical record according  of AMI death in the government hospital Malaysia 1990-
1998)(MOH, 1990-1998). Cardiovascular disease accounted for 25% of all deaths in 
Malaysia. In 2001, ACS apparently accounted for nearly 35,000 acute admissions into 
Government hospitals in Malaysia.Half of heart failure causes are related to left ventricular 
diastolic dysfunction, and heart failure is one of the important causes of mortality in heart 
disease patients (Vasan et al., 1995; Betocchi and Hess, 2000). In 2006, there were 12,534 
admissions due to ACS in Malaysia. As an estimate, the incidence of CAD in Malaysia is 141 
per 100,000 population according to provision of coronary care services in Malaysia, 
 
 Development of left ventricular diastolic dysfunction is a frequent complication after 
acute myocardial infarction (AMI), and it is associated with an increased risk of heart 
failure.Coronary artery disease is most commonly due to atherosclerotic occlusion of the 
coronary arteries(Poulsen et al., 1999). The main risk Factors for Atherosclerotic Coronary 
Artery Disease are: 
1. Dyslipidemias; particularly high low density cholesterol (LDL-C) and low high density 
cholesterol (HDL-C). (ATP III classification of LDL, total and HDL cholesterol; LDL-C: 
Optimal < 100 mg/dL, Near or above optimal 100-139 mg/dL, Borderline high 140-159 
mg/dL, high > 160 mg/dL, total cholesterol: desirable < 200mg/dl, borderline high 200-239 
mg./dL, high > 240 mg./dL, HDL: Low < 40 mg./dL. (Owan et al., 2006) 
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2. Hypertension; According to WHO, about 1.5billion people suffer from Hypertension 
worldwide, seven million die each year due to hypertension. Hypertension (50 million in the 
US, 1/3 undiagnosed, 3/4 under treated). (Classification of HTN Normal BP: systolic < 120 
mmHg AND diastolic < 80 mmHg, Pre-hypertension: systolic 120-139mmHg OR diastolic 
80-89 mmHg, Hypertension: systolic >140mmHg OR diastolic > 90 mmHg. The 7th Joint 
National Committee (7JNC) (Snow et al., 1990). 
3. Diabetes mellitus (8% of US population). According to Malaysian National Health survey, 
DM has risen to 11.6% in 2006. (Classification: Normal fasting glucose < 110 mg/dL 
(6.1mmol/l) Impaired 110- 126 mg/dL (6.1-7mmol/l), diabetes > 126 mg/dL)(>7mmol/l). 
4. Smoking (most important modifiable risk factor), CAD accounts for 35%-40% of 
all smoking related deaths. 
5. Family history of premature coronary artery disease (CAD); First degree male relatives < 
55 years or females < 65 years. 
6. Obesity (18% of US population) and lack of exercise 
7. Male sex and advanced age 
8. Others (20% of CAD occurs in individuals without any of the classical risk factors); 
homocysteinemia, high sensitivity C reactive protein (hs-CRP), Fibrinogen, Lipoprotein a 
(Lpa), infection (? Chlamydia pneumoniae). These are emergent newer risk factors. 
 
1.2 Pathophysiology of Ischemic Heart disease 
 
Coronary atherosclerosis is initially characterized by fatty streaks, which are 
associated by functional alterations of the endothelium without significant reductions in the 
vessel diameter. Hypercholesterolemia, circulating vasoactive amines, chemical irritants such 
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as tobacco smoke, and inflammatory processes promote endothelial dysfunction. These early 
lesions also involve accumulation of lipids, macrophages, and T-lymphocytes  
 
in the arterial vessel wall. Fatty streaks are never associated with cardiac symptoms 
and may disappear or develop into atheromata. Platelets, endothelial cells, and macrophages 
may secrete several growth factors that initiate proliferation and migration of smooth muscle 
cells to other layers of the vessel wall. Endothelial dysfunction and smooth muscle cell 
proliferation may result in lesions of the more inward (intimal) layers of the coronary vascular 
wall. These coronary lesions display fibrin deposits and/or lipid-laden phagocytes (i.e., foam 
cells). Endothelial activation can be caused by low-density lipoprotein (LDL) cholesterol 
modification by oxidation resulting in the release of phospholipids. Platelets first respond to 
activated endothelium and may further increase endothelial activation by their glycoproteins 
(Ib and IIb/IIIa). Subsequently, a capsule-like fibrous layer of smooth muscle cells is formed, 
which covers the lipid lesion and predominantly collagen-based matrix. The atherosclerotic 
lesion is infiltrated by T-cells, macrophages, and mast cells, particularly at sites where the 
plague grows. These activated immune cells produce inflammatory cytokines which can be 
detected in the systemic circulations. Atherosclerotic plagues at the advanced stage of  CAD 
are characterized by severe damage to all layers of the vessel wall, including the elastic 
lamina. Because of the thin layer of lipid-laden lesions, plague rupture can easily occur, 
causing blood-clot formation and development of severe vascular lesions, even when 
obstructive luminal narrowing has not yet been developed. 
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Figure 1 Pathophysiology of ischemic Heart disease Adopted from (Otto, 2012) 
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CHAPTER TWO 
 LITERATURE REVIEW 
2.1 Diastolic function 
Diastolic function encompasses several distinct haemodynamic phases which are 
fundamentally different in their properties. Echocardiography has been the mainstay for 
understanding the physiology of diastolic function and identifying the pathophysiology of 
diastolic dysfunction.  
2.1.1 Physiology of diastole 
Diastole was defined by Wiggers in physiologic terms as a process extending from the 
opening of the mitral valve i.e. the onset of ventricular filling to the onset of the contraction. 
For clinical application, diastole commence at the onset of the second heart sound indicating 
closure of the aortic valve and ended with the first heart sound, indicating closure of the mitral 
valve(Galiuto et al., 2011).  It is divided into four phases; 
1. Isovolumic relaxation – which is the time between aortic valve closure and mitral 
valve opening. 
2. Rapid early filling – account for 80% of ventricular filling. 
3. Slow filling / Diastasis – account for less than 5%. 
4. Late filling from atrial contraction. 
1. Isovolaemic relaxation  
By definition this is a period that extends from the time of aortic valve closure to mitral valve 
opening, and it occurs without a change in LV volume. It is an energy dependent process 
which occurs until mid-diastole.  
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2. Early rapid filling phase 
This starts with opening of the mitral valve. The blood leaves the left atrium and enters the 
left ventricle passively down a pressure gradient generated by continued ventricular 
relaxation. This phase is therefore commonly termed the passive filling phase of ventricle, 
even though relaxation is active, an energy requiring process. Left ventricular suction, 
continued LV relaxation and elastic recoil leads to a continued fall in LV pressure, resulting 
in development of LA to LV pressure gradient with subsequent blood acceleration. This 
gradient is influenced by the level of left atrial pressure at mitral valve opening and rate of 
decline of ventricular pressure. Blood rapidly enters the LV from LA during the early filling 
period with approximately 70% of stroke volume received by the LV during the first third of 
diastole(Galiuto et al., 2011). 
3. Diastasis 
This term is applied to the phase in diastole when LA and LV pressure are essentially in 
equilibrium following the rapid filling phase and little or no filling occurs; hence diastasis 
occurs between rapid filling and atrial contraction phase. It accounts for less than 5% of 
ventricular filling. 
4. Late filling phase (atrial systole) 
In the presence of sinus rhythm, synchronous electrical activation of the left atrium is 
followed by atrial contraction and ejection of further amount of blood into the left ventricle. 
Increase end diastolic volume by 25-30% of total filling volume of the ventricle. Naturally 
this phase of ventricular filling is absent in AF. Normally very little retrograde flow of blood 
into pulmonary veins occurs, and practically all the blood ejected by the atrium enters the 
ventricle. 
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2.1.2 Determinants and Properties of LV Diastolic Function 
The following are major determinants of diastolic function; 
1) Active myocardial relaxation 
2) LV compliance 
3) LA function 
4) Heart rate  
5) The pericardium 
1. Active myocardial relaxation 
Relaxation maybe defined broadly as the process by which muscle returns from its 
contracted state to that which existed before the initiation of the contraction. Abnormalities of 
relaxation may occur with myocardial ischaemia with hypoxia (such as in coronary artery 
disease), myocardial hypertrophy, hypothyroidism, hypothermia, aging, and a variety of other 
conditions. 3 main controlling mechanisms has been identified, these are; inactivation, load 
and in the case of intact ventricle, heterogeneity of inactivation of the ventricular chamber.  
- Inactivation: refers to the disengagement of actin-myosin cross bridges within the 
myocardial cell, the prior formation of which is the subcellular mechanism responsible for 
myocardial contraction. 
- Load: relaxation loads are those loads that are presence during the period of relaxation. Of 
there, internal restoring forces refer to the intrinsic forces created by the deformation of 
myocardial geometry resulting from contraction. 
- Heterogeneity of relaxation: when different segments of the ventricle relax assynchronously, 
some segment may commence relaxation when others are almost fully relaxed. The resulting 
effect is a reduction in chamber or global relaxation rate. Such heterogeneity of regional 
relaxation may occur because of regional ischaemia or infarction in CAD or as a result of an 
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abnormal sequence of electrical depolarization seen with ventricular pacing or intra-
ventricular conduction defect. 
2. LV Compliance 
Ventricular compliance is the ratio of change in volume to change in pressure (dv/dp) and 
stiffness is the mathematical inverse of compliance (dp/dv). Compliance is the net result of a 
variety of factors; visco-elastic nature of the myocardium, chamber size, shape, and wall 
thickness, RV and LV pressure volume interactions, pleural pressure and pericardial 
characteristics. 
3. Left atrium 
LA predominantly acts as a passive reservoir of blood during early LV filling, and as an 
active pump at end diastole. Atrial systolic function (active phase) may be essential to 
maintain cardiac output in disease states. 
4. Heart rate 
Heart rate has a direct effect on cardiac output in cases of diastolic dysfunction. As heart rate 
increases, diastolic filling period preferentially decreases with respect to the systolic ejection 
period.  
 Other factors that affect diastolic function include neuro-hormonal activation, 
conduction abnormalities and the stiffness of pericardium. 
 
2.2 Echocardiographic Assessment of Diastolic Function 
Although LV diastolic function can be assessed by cardiac catheterization, non-
invasive methods such as Doppler recording of trans mitral and pulmonary venous flow and 
Tissue Doppler can provide adequate and accurate information and are currently the most 
widely used in clinical practice. 
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 Echocardiography has been the mainstay for understanding the physiology of diastolic 
function and identifying the pathophysiology of diastolic dysfunction. A large number of 
parameters have been used to measure many aspects of diastolic function, and this diversity in 
itself reflects the absence of a single index that is ideal or universally acceptable. Therefore 
the combination of different techniques and/or maneuvers is needed in order to allow for an 
effective clinical staging of LV diastolic dysfunction. 
 In current clinical practice, the clinician has a number of techniques in the evaluation 
of diastolic function which include traditional and widely used Doppler techniques - mitral 
inflow and pulmonary vein flow ; and newer techniques such as Color M-mode Doppler and 
tissue Doppler imaging. 
Doppler techniques of evaluating diastolic function 
1) Mitral inflow: 
 In the evaluation of diastolic function of the left ventricle (mitral inflow), perform PW 
Doppler in the apical 4 chamber view with the sample volume placed at the tips of the mitral 
valve leaflets. Obtain a PW Doppler trace and measure: 
• Peak E wave velocity 
• Peak A wave velocity 
• E/A ratio 
• E wave deceleration time (DT) 
• Isovolaemic relaxation time (IVRT) 
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Figure 2  Mitral Inflow at apical 4 chamber view  Adopted from (Houghton and Gray, 
2008) 
E wave 
 Represent the early filling phase of Left ventricle. In healthy individual, the early flow 
coincide with the mitral E-wave spectra, exceeds the later flow which occur with atrial systole 
- the A-wave (peak atrial systolic velocity spectra) 
DT 
 E-wave deceleration time is the time period between the peak of the E-wave and the 
end of the E-wave, measured by extrapolating the E-wave deceleration slope down to the 
baseline and is normally 150-240 millisecond. 
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IVRT 
 This is the time period between aortic valve closure and mitral valve opening, during 
which LV pressure falls but there is no change in LV volume. There are various methods of 
measuring IVRT. The simplest is to tilt the probe, obtain a 5 chamber view and adjust the PW 
Doppler sample volume to lie between the mitral and aortic valves (so that both the mitral 
inflow and aortic outflow traces are seen on the same PW Doppler trace). Freeze the spectral 
trace and measure the time period between the end of aortic outflow trace and the start of the 
mitral inflow trace, this is the IVRT and normally 50-100 milliseconds. 
 
Figure 3 Isovolumic Relaxation Time (IVRT) Adopted from (CACP, 2007) 
2) Tissue Doppler Imaging (TDI) of the mitral annulus 
 In the recent time, there has been tremendous interest in the prognostic implications of 
TDI diastolic variables. TDI of the mitral annulus is undertaken in the apical 4-chamber view, 
place the sample volume in the myocardium of the septum and/or lateral wall. The optimal 
location is 1cm before the mitral annulus. In each location a tissue doppler recording should 
be made using a low gain setting and aliasing velocity 12-20cm/s. TDI can be used as stand-
alone technique or combine with mitral inflow pattern. TDI recording shows an early 
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myocardial velocity (Em or E') which corresponds to the early diastolic relaxation, the 
myocardium moving away from the transducer.  
 This is followed by a further movement away from the transducer corresponding to the 
atrial contraction (Am or A'). Normally E’ > A' when E’/A’ ratio is in the range of 1-2. If 
there is diastolic dysfunction, this ratio reverses. The ratio between the peak LV inflow E 
wave and E' should also be calculated, it reflects LA pressure. Normal E/E' ratio are less than 
8 at the septum and less than 10 at the lateral wall. 
The normal ratio of  E' to A' is over 1.0. A reduced E' to A' ratio indicates impaired relaxation. 
The pattern of E’ to A' also helps to distinguish normal LV filling from the pseudo 
normalization pattern seen in patients with moderate diastolic dysfunction. 
Approximate values for TDI derived variables are: 
                  E' - 10 ± 2.0cm/s 
                  A' - 5.8 ± 1.6cm/s 
                  E'/A' - 2.1± 0.9 
 
Figure 4  Tissue Doppler Imaging Technique Adopted from (Otto, 2012) 
1) Tricuspid annulus;   2) Basal ventricular septum;  3) Mitral annulus. 
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Figure 5   Doppler tissue imaging adopted from (Saccheri et al., 2006) 
 A' indicates atrial systole; E', rapid ventricular filling; S', systolic contraction; IVC, 
isovolumic contraction; IVR, isovolumic relaxation; RA, right atrium; LA, left atrium. 
 
3) Pulmonary venous flow 
To assess pulmonary venous flow, obtain PW Doppler in the apical 4-chamber view with the 
sample volume placed inside one of the pulmonary veins, the right upper pulmonary vein is 
usually easiest to locate(Otto, 2012). 
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Figure 6  Pulmonary vein Flow Technique Adopted from (Otto, 2012) 
 
Pulmonary vein flow normally consists of three (3) components: 
• The S-wave represents forward flow into the left atrium during the ventricular systole. 
• D-wave which is smaller represents forward flow during ventricular diastole. 
• 'a' wave - if the patient is in sinus rhythm, the S and D waves are followed by 'a' wave 
representing flow reversal in the pulmonary vein during atrial systole. 
Obtain a PW Doppler trace and measure; 
• peak systolic (S wave) velocity (PVS) 
• peak diastolic (D wave) velocity (PVD) 
• peak atrial reversal (a wave) velocity (PVa) 
• duration of atrial reversal (adur) 
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Normally PVS> PVD, and PVa< 0.35ms 
4) Color M-mode flow propagation velocity 
 Colour M-mode of the mitral inflow recorded by placing the M-mode cursor in the 
direction of the mitral inflow jet may be used to assess LV relaxation. The slope method is the 
most widely used in calculating velocity flow propagation [Vp cm/s]. In normal LV, values of 
Vp are greater than 30cm/s. In myocardial ischaemia or heart failure, there is slowing of Vp 
which is consistent with a reduction in apical suction. In normal subjects during diastole, there 
is a wave of relaxation originating at apex and moving toward the base which result in LV 
base to apex pressure gradient and allows blood flow to be sucked into the LV. 
 
2.3 Mechanism of Diastolic Dysfunction 
The evolution of diastolic dysfunction is complex, it involves the following: 
 Myocardial relaxation is an active process influencing isovolumic relaxation phase and 
part of the early filling phase. Factors affecting myocardial relaxation includes intracellular 
calcium overload (e.g. ischemia) which can delay or prolonged myocardial relaxation such 
that it impinges on early filling phase of diastole. Ventricular compliance is passive process 
that influences all three phases of diastole. 
 Besides myocardial relaxation and ventricular compliance, characteristics of 
pulmonary veins, left atrium and mitral valve are also involved in diastolic function. Heart 
rate is also a determinant of diastolic function. In the presence of bradycardia; most of the LV 
filling occurs before atrial contraction. In contrast, in presence of tachycardia, early filling is 
truncated and there is no diastasis phase.(Bursi et al., 2006).  
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2.4 Diastolic dysfunction  
Diastolic dysfunction is an abnormal function of the heart during atrial relaxation 
phase and compromises the heart ability to relax and fill. 
Increase in left ventricular filling pressure (LVFP) is the main pathophysiological 
consequence of diastolic dysfunction. It is mainly determined by filling and passive properties 
of LV walls and can be additionally controlled by incomplete LV relaxation and alterations of 
myocardial diastolic tone. 
 Many patients with ischaemic heart disease show abnormal diastolic function on TDI 
despite having normal systolic function. In acute myocardial infarction, a pattern of delayed 
relaxation is seen acutely.  
Causes of diastolic dysfunction 
1) Ischaemic heart disease 
2) LV hypertrophy e.g., hypertension, AS, HOCM 
3) Restrictive cardiomyopathy 
4) Constrictive pericarditis 
5) Left ventricular infiltrations e.g., amyloid, sarcoid, carcinoid, hemochromatosis 
6) Aging effects  
Causes often co-exists e.g., hypertension, coronary artery disease 
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2.4.1 Mechanism of Diastolic Dysfunction 
The evolution of diastolic dysfunction is complex, it involves the following: 
Myocardial relaxation is an active process influencing isovolumic relaxation phase and part of 
the early filling phase. Factors affecting myocardial relaxation includes intracellular calcium 
overload (e.g. ischemia) which can delay or prolonged myocardial relaxation such that it 
impinges on early filling phase of diastole.  
2.4.2 Grading of diastolic dysfunction 
There are 4 grades of diastolic dysfunction; 
Grade 1:  Represent impaired/ slows early left ventricular relaxation. At this point a patient is 
usually asymptomatic with normal filling pressure.  
Doppler findings include: 
• E/A ratio <1.0 
• Deceleration time >240 msec. 
• IVRT >90 msec. 
• Pulmonary vein ‘’a’’ wave flow reversal <25 cm/sec. 
Grade 2 : Pseudo normalisation. At this stage the effect of impaired/ slow early left 
ventricular relaxation on early diastolic filling become opposed by the elevated left atrial 
pressure and the early diastolic trans mitral pressure gradient and mitral flow velocity pattern 
return to normal, this phenomenon is called pseudo-normalisation to indicates that although 
left ventricular filling appears normal, significant abnormalities of diastolic function are 
present. This can be unmasked by valsalva manoeuvre or more evaluated by TDI method. 
Grade 3: Restrictive but reversible represent a severe decrease in left ventricular chamber 
compliance but is reversible. 
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Grade 4:  Restrictive but irreversible, diastolic filling pressures are elevated and the patient is 
markedly symptomatic. The left atrium is dilated and hypo-contractile. 
Doppler findings: 
• E/A ratio >1.5 
• IVRT < 60m/sec 
• Deceleration time < 160 m/sec 
   Normal echocardiographic diastolic function parameters 
• E/A ratio:   normal  1.1 to 1.5 
• Deceleration time:  160 to 240 msec. 
• IVRT:  76 +/- 13 (>40 years)  
 69 +/- 12 (<40 years)  
• Pulmonary vein “a “ wave flow reversal < 25 cm/ sec 
       Normally E>A  
       Abnormal relaxation E<A 
      Pseudo-normal filling E>A 
Restrictive filling         E>> 
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Figure 7  Grading of Diastolic Dysfunction  adopted from (Otto, 2012) 
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Figure 8  Echocardiographic Grading of Diastolic Dysfunction (Adopted from 
(http://www.echobasics.de/diastole-en.html)) 
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2.5 The Ischemic cascade 
 The Ischaemic cascade is a sequence of hemodynamic and cardiac electro physiologic 
changes that culminates in angina. It is initiated by an imbalance between myocardial oxygen 
supply and demand. 
Abnormal myocardial perfusion is the first detectable event of the ischaemic cascade as 
follows: 
 
 
 
Figure 9   Ischemic cascade adopted from (Galiuto et al., 2011) 
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Figure 10  Sequence of ischemic cascade adopted from (CACP, 2007) 
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2.6 Percutaneous coronary intervention (PCI) 
 Since the first human percutaneous trans luminal coronary angioplasty (PTCA) 
procedure was performed in 1977, the use of percutaneous coronary intervention (PCI) has 
increased dramatically becoming one of the most common medical interventions performed. 
Coronary angioplasty has multiple indications including: unstable angina, acute myocardial 
infarction and multi-vessel coronary artery disease. With the combination of sophisticated 
equipment, experience operator and modern drug therapy, PCI has evolved into an effective 
non-surgical modality for treating patients with coronary artery disease. Annually, PCI is 
done in one million cases in the United States and two million around the world (Cutlip et al. 
2007). 
 PCI is performed through the femoral, radial or brachial artery. A guiding catheter is 
placed in the ostium of the diseased coronary artery, a 0.014inch guide wire is advanced 
through the lesion and a balloon catheter is introduced over the guide wire and placed in the 
stenosed area. Usually the balloon is inflated for 15-30 seconds by 6 atmospheres. 
 Opening the thrombotic occlusion of the infarct related coronary artery in acute MI is 
effective in reducing the infarct size thereby preserving the LV function. In 1997, Weaver at 
el. showed a 32% mortality reduction in primary PCI compared to fibrinolysis. The 
CADILLAC trial demonstrated additional benefit of stenting versus balloon angioplasty in 
AMI. Diastolic abnormalities of left ventricular relaxation and filling now appear to be the 
earliest manifestation of myocardial ischemia and contribute to hemodynamic derangement 
and symptomatology. It has been suggested that abnormalities of left ventricular diastolic 
functions may actually proceed left ventricular systolic dysfunction in CAD and therefore 
serve as an early and sensitive marker of ischemia. 
